92771-89-6

Upstream product

• 105-13-5 4-Methoxybenzyl alcohol 
• 2746-25-0 p-Methoxybenzyl bromide 
• 64370-69-0 bis-(p-methoxybenzyl) tartrate 

Downstream Products

• 125013-10-7 (5R)-p-methoxybenzyl 6-<(Z)-(1-methyl-1H-1,2,3-triazol-4-yl)methylene>-7-oxo-1-azabicyclo<3.2.0>hept-2-ene-2-carboxylate 
• 125013-09-4 (5R)-p-methoxybenzyl 6-<(E)-(1-methyl-1H-1,2,3-triazol-4-yl)methylene>-7-oxo-1-azabicyclo<3.2.0>hept-2-ene-2-carboxylate 
• 138477-46-0 (5R)-p-methoxybenzyl 6-(Z)-ethylidene-7-oxo-1-azabicyclo<3.2.0>hept-2-ene-2-carboxylate 
• 138477-47-1 (5R)-p-methoxybenzyl 6-(E)-ethylidene-7-oxo-1-azabicyclo<3.2.0>hept-2-ene-2-carboxylate 
• 125013-04-9 (3'R,4'R)-p-methoxybenzyl (4'-allyl-3'-bromo-2'-oxoazetidin-1'-yl)(triphenylphosphoranylidene)acetate 
• 138477-45-9 (R)-6-(1-Acetoxy-ethyl)-6-bromo-7-oxo-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylic acid 4-methoxy-benzyl ester 
• 138477-44-8 ((2R,3R)-2-Allyl-3-bromo-4-oxo-azetidin-1-yl)-chloro-acetic acid 4-methoxy-benzyl ester 
• 125013-06-1 (5R,6R)-p-methoxybenzyl 6-bromo-7-oxo-1-azabicyclo<3.2.0>hept-2-ene-2-carboxylate 
• 92772-01-5 {(2R,3S)-3-[(R)-1-(tert-Butyl-dimethyl-silanyloxy)-ethyl]-2-[2-(1-carbamoylmethyl-1H-tetrazol-5-ylsulfanyl)-acetylsulfanyl]-4-oxo-azetidin-1-yl}-(triphenyl-λ⁵-phosphanylidene)-acetic acid 4-methoxy-benzyl ester 
• 92771-95-4 ((2R,3S)-3-[(R)-1-(tert-Butyl-dimethyl-silanyloxy)-ethyl]-2-{2-[1-(2-hydroxy-ethyl)-1H-tetrazol-5-ylsulfanyl]-acetylsulfanyl}-4-oxo-azetidin-1-yl)-(triphenyl-λ⁵-phosphanylidene)-acetic acid 4-methoxy-benzyl ester 
• 92771-91-0 (3S^*,4R^*)-3-<(R^*)-1-hydroxyethyl>-1-(p-methoxybenzyloxycarbonyl)triphenylphosphoranylidenemethyl-4-triphenylmethylthio-2-azetidinone 
• 92771-93-2 {(2R,3S)-3-[(R)-1-(tert-Butyl-dimethyl-silanyloxy)-ethyl]-2-[2-(1-methyl-1H-tetrazol-5-ylsulfanyl)-acetylsulfanyl]-4-oxo-azetidin-1-yl}-(triphenyl-λ⁵-phosphanylidene)-acetic acid 4-methoxy-benzyl ester 
• 92772-06-0 {(3S,4R)-3-[(R)-1-(tert-Butyl-dimethyl-silanyloxy)-ethyl]-2-oxo-4-[2-([1,3,4]thiadiazol-2-ylsulfanyl)-acetylsulfanyl]-azetidin-1-yl}-(triphenyl-λ⁵-phosphanylidene)-acetic acid 4-methoxy-benzyl ester 
• 92772-02-6 [(2R,3S)-2-[2-(1-Carbamoylmethyl-1H-tetrazol-5-ylsulfanyl)-acetylsulfanyl]-3-((R)-1-hydroxy-ethyl)-4-oxo-azetidin-1-yl]-(triphenyl-λ⁵-phosphanylidene)-acetic acid 4-methoxy-benzyl ester 

Relevant academic research and scientific papers

Synthesis of 6-(Substituted Methylene) Carbapenem Derivatives from 6-Aminopenicillanic Acid

The key intermediate in the preparation of novel 6-(substituted methylene) carbapenem derivatives is p-methoxybenzyl (5R,6R)-6-bromo-7-oxo-1-azabicyclohept-2-ene-2-carboxylate 26, which was prepared in several steps from 6-aminopenicillanic acid 14 via (3R,4R)-4-allyl-3-bromoazetidin-2-one 21.Sequential treatment of the aforementioned ester 26 with either lithium diisopropylamide or lithium diphenylamide, 1-methyl-1H-1,2,3-triazole-4-carbaldehyde and acetic anhydride provided a diastereoisomeric mixture of acylated bromohydrins 28; reductive elimination then afforded the isomeric (E)- and (Z)-6-triazolylmethylene carbapenem esters 29 and 31, respectively.Lewis acid-mediated deprotection of the 6-bromo and 6- esters 26 and 29 gave the sodium salts of (5R,6R)-6-bromo-7-oxo-1-azabicyclohept-2-ene-2-carboxylic acid 27 and (5R)-6--7-oxo-1-azabicyclohept-2-ene-2-carboxylic acid 30, respectively.In addition, condensation of the anion, generated by deprotonation of the 6-bromo ester, with acetaldehyde, followed by acylation and reductive elimination furnished the isomeric (E)- and (Z)-ethylidene carbapenem esters.Whilst the (E)-6-triazolylmethylene carbapenem displayed low levels of antibacterial activity, it possessed no β-lactamase-inhibitory activity whatsoever.The 6-bromocarbapenem was devoid of both antibacterial and β-lactamase-inhibitory activity.